glp-1 medication gonzales Prescription GLP-1s for Weight Loss Transformative GLP-1 Weight Loss Program

Jiang G, Zhang BB

Figure 23: Photograph of Professor Graeme Bell in San Francisco taken by Mitsuko Seino in the parking lot of Chiron Corporation, 1984, credit: Accili, Bell

"Since there are no head-to-head trials comparing oral semaglutide for obesity to orforglipron, this indirect treatment comparison from the ORION study provides important information that can be used during the shared decision-making process." Additionally, OPTIC was an online patient preference study assessing key factors driving obesity treatment decisions conducted from October to November 2025

Anthem commercial plans in Michigan that may include GLP-1 or obesity medication coverage include certain PPO and HMO plans where the employer has elected to include obesity drug benefits

Research confirms that GLP-1 medications produce substantial, sustained weight reduction when combined with lifestyle modifications

Results: 397 (54%) patients were A-MASLD, 290 (40%) LAC-MASLD and 42 (6%) met-ALD